Key Takeaways
- Dr. Aydin Huseynov joins Ladenburg Thalmann as Managing Director in the Healthcare Investment Banking Group.
- He will focus on enhancing the firm’s biotechnology investment banking platform through strategic insights and industry relationships.
- Dr. Huseynov has a strong background in medicine and finance, previously serving as Managing Director in Equity Research at Ladenburg.
New Leadership in Healthcare Investment Banking
Ladenburg Thalmann & Co. Inc., a prominent middle-market investment bank, has appointed Dr. Aydin Huseynov as Managing Director within its Healthcare Investment Banking Group, specializing in biotechnology. Dr. Huseynov’s role will include expanding the firm’s biotechnology investment banking capabilities and fostering relationships within the industry.
Dr. Huseynov is well-equipped for this position due to his extensive experience in biotechnology, clinical development, and capital markets. Before his appointment, he served as Managing Director in Equity Research at Ladenburg, focusing on the biotechnology sector. This transition marks a shift from research to a dedicated investment banking focus, leveraging his strong relationships with both company management and institutional investors.
Barry Steiner, Co-President and Co-CEO of Ladenburg Thalmann, noted that Dr. Huseynov’s combination of medical training and biotechnology expertise enhances the firm’s ability to engage effectively with innovative companies. Nicholas Stergis, Co-Head of Investment Banking, expressed enthusiasm for Dr. Huseynov’s unique skill set, which includes medical knowledge and robust corporate and investor relationships.
Dr. Huseynov holds a Medical Doctorate (M.D.), an MBA from Duke University, and is a CFA charter-holder. His previous positions include strategy consulting at Syneos Health Consulting, investment banking at MTS Health Partners, and biotechnology equity research roles at firms such as Oppenheimer and The Benchmark Company. He is based in Ladenburg Thalmann’s New York City office.
Ladenburg Thalmann offers a comprehensive range of financial services, including investment banking, equity and debt capital raising, mergers and acquisitions, and corporate finance advisory. Established in 1876, it has been a member of the New York Stock Exchange since 1879.
The content above is a summary. For more details, see the source article.